Clinical trials
Alopecia clinical trials
Below are recruiting alopecia clinical trials, each written for real people, not researchers. We’re tracking 82 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07603544Recruiting
Hair Loss Study: Understanding Male Pattern Baldness
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
Xinxiang, HenanAges 20–65 - NCT07554222RecruitingPhase 1
Safety study of IBI3013 for vitiligo and hair loss
This is an early-stage safety study of a new drug called IBI3013. The trial tests how safe the drug is and how your body processes it. It enrolls healthy volunteers first, then people with vitiligo (loss of skin color) or severe alopecia areata (patchy hair loss).
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07536100Recruiting
New Hair Growth Serum vs. Minoxidil for Hair Loss
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
Bangkok, BangkokAges 18 years+ - NCT07533006RecruitingPhase 2
Study of a new treatment for severe hair loss
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
Fremont, CaliforniaAges 18–60 - NCT07502976Recruiting
Hair growth gel vs minoxidil for male and female hair loss
This trial tests a new gel made from a natural sugar molecule against a standard hair loss treatment (minoxidil). It aims to see which works better for people with mild to moderate hereditary hair loss.
Cairo, Cairo GovernorateAges 18–50 - NCT07487948RecruitingPhase 2
Testing the drug delgocitinib for two types of scarring hair loss
This study tests an oral medication called delgocitinib, which targets certain enzymes linked to inflammation, in people with central centrifugal cicatricial alopecia (CCCA) or lichen planopilaris (LPP). It aims to see if the drug is safe and if it changes biomarkers (biological signals) related to these conditions.
New York, New YorkAges 18 years+ - NCT07429253RecruitingPhase 1/Phase 2
Secretome vs. PRP for male and female hair loss
This trial compares two treatments—secretome and platelet-rich plasma (PRP)—to see which helps grow thicker, denser hair in people with genetic hair loss (androgenetic alopecia). It's for adults aged 25 to 59 who have stopped taking certain hair loss medications for at least a month.
Denpasar, BaliAges 25–59 - NCT07435012RecruitingPhase 3
Hair loss treatment trial for men ages 18 to 49
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
Vancouver, British ColumbiaAges 18–49 - NCT07422376Recruiting
Scalp cooling for hair loss during chemo
This study tests if a cooling cap can help reduce hair loss during chemotherapy for breast cancer. Hair loss can be distressing, and this trial aims to see if the cap helps you keep more hair while still getting the treatment you need.
Kingsport, TennesseeAges 18 years+ - NCT07397325RecruitingPhase 1/Phase 2
Study of a cooling cap to prevent hair loss from chemo
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
ManausAges 18–65 - NCT07370519RecruitingPhase 2
Probiotic lotion for hair loss
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
Shenzhen, GuangdongAges 18–60 - NCT07340671Recruiting
Laser treatment for facial bumps in frontal fibrosing alopecia
This study tests whether laser therapy can help treat small bumps (papules) that appear on the face in people with frontal fibrosing alopecia, a type of hair loss. If you have these bumps and are generally healthy, you may be able to join.
Miami, FloridaAges 18 years+ - NCT07327359RecruitingPhase 1/Phase 2
Hair loss treatment for men with male pattern baldness
This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.
Botany, New South WalesAges 18–59 - NCT07317544RecruitingPhase 1/Phase 2
ABS-201 trial for hair loss in healthy adults
This trial tests a new medicine (ABS-201) in healthy people to see if it is safe and works for hair loss. It involves multiple doses and compares results based on whether you have the common type of hair loss called androgenetic alopecia.
Sydney, New South WalesAges 18–65 - NCT07311564RecruitingPhase 2
Study of LAD603 for adults with severe alopecia areata
This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.
Omaha, NebraskaAges 18–65 - NCT05484973Recruiting
Portable scalp cooling to help prevent chemotherapy hair loss
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
Tucson, ArizonaAges 21 years+ - NCT07205159RecruitingPhase 1
A study of FB102 for severe alopecia areata
This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.
Saint Leonards, New South Wales (nsw)Ages 18–75 - NCT07203599RecruitingPhase 1/Phase 2
Stem cell exosomes for male pattern baldness
This trial tests a treatment made from umbilical cord stem cell exosomes for young men with male pattern baldness. It aims to see if this natural substance can help regrow hair.
Shenzhen, GuangdongAges 18–35 - NCT07152119Recruiting
Study of Litfulo for severe alopecia areata in routine care
This study looks at how well Litfulo capsules work for people with severe alopecia areata in everyday medical practice. It is for adults and teens aged 12 or older who are starting Litfulo as part of their normal care.
SeoulAges 12 years+ - NCT07136467Recruiting
Understanding daily life with vitiligo, alopecia areata, or hidradenitis suppurativa
This study looks at how certain skin conditions affect daily life in teens and adults. Researchers want to understand the challenges people face with vitiligo, alopecia areata, or hidradenitis suppurativa by having participants fill out simple questionnaires.
Ciudad Autonoma de Buenos Aire, Buenos AiresAges 12 years+ - NCT07133308RecruitingPhase 3
Study of deuruxolitinib for teens with severe alopecia areata
This study tests an investigational oral medication (deuruxolitinib) for adolescents with severe alopecia areata (hair loss). It aims to see if it can help hair regrow safely.
Birmingham, AlabamaAges 12–17 - NCT07080931RecruitingPhase 3
Minoxidil foam for female hair loss
This trial tests a 5% minoxidil foam to treat female pattern hair loss. It may help women who have been diagnosed with this condition and have mild to moderate hair thinning.
BeijingAges 18 years+ - NCT07079657Recruiting
Thulium laser and growth factors for hair loss
This trial tests whether a special laser combined with growth factor injections can help regrow hair in people with common hereditary hair loss (androgenetic alopecia). It aims to find a new treatment option that may work better than current methods.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT07049328RecruitingPhase 1
Study of HCW9302 for Alopecia Areata
This trial tests a new drug, HCW9302, that targets the immune system to help hair regrow in people with alopecia areata (including extensive forms like totalis or universalis). It may be an option for adults who have not responded well to other treatments.
Tampa, FloridaAges 18–70
Hear when a new Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alopecia?
- Yes. Clin2 currently lists 82 recruiting alopecia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alopecia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alopecia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.